Back to Search

JULIA SEIN, MD

MD

Retina Specialist (Ophthalmology) Physician

NPI: 1295178291IndividualAccepts Medicare

Specialties, Licenses & Credentials

Ophthalmology Physician

Ophthalmology

Code: 207W00000X

A167360(CA)
Retina Specialist (Ophthalmology) PhysicianPrimary

Ophthalmology — Retina Specialist

Code: 207WX0107X

A167360(CA)

CMS Specialties

PrimaryOPHTHALMOLOGY

Education

UNIVERSITY OF MIAMI, LM MILLER SCHOOL OF MEDICINE

Class of 2013

Research & Publications (11)

Band-selective 1H-13C cross-polarization in fast magic angle spinning solid-state NMR spectroscopy.
PMID 19053413·J Am Chem Soc·2008
8-other
The refocused INADEQUATE MAS NMR experiment in multiple spin-systems: interpreting observed correlation peaks and optimising lineshapes.
PMID 17588789·J Magn Reson·2007
8-other
The role of (15)N CSA and CSA/dipole cross-correlation in (15)N relaxation in solid proteins.
PMID 17280844·J Magn Reson·2007
8-other
Observation of heteronuclear overhauser effects confirms the 15N-1H dipolar relaxation mechanism in a crystalline protein.
PMID 16984173·J Am Chem Soc·2006
8-other
Immunogenicity, including vitiligo, and feasibility of vaccination with autologous GM-CSF-transduced tumor cells in metastatic melanoma patients.
PMID 16260696·J Clin Oncol·2005
3-trial
Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
PMID 16115526·Eur Urol·2005
3-trial
On the role of melanoma-specific CD8+ T-cell immunity in disease progression of advanced-stage melanoma patients.
PMID 15269149·Clin Cancer Res·2004
8-other
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.
PMID 12778059·Br J Cancer·2003
3-trial
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma.
PMID 12610499·Br J Cancer·2003
8-other
Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.
PMID 11773154·J Clin Oncol·2002
3-trial
Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.
PMID 10778950·Clin Cancer Res·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
27335 TOURNEY RD STE 210
VALENCIA, CA 91355

Location

Practice Location

27335 TOURNEY RD STE 210, VALENCIA, CA
(661) 455-7797

Quick Facts

NPI
1295178291
Entity Type
Individual
Gender
Female
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
13
Publications
11

Are you this provider?

Claim Your Profile